Dr. Caldera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1685 Highland Ave
# 4256
Madison, WI 53705Phone+1 608-263-1995
Summary
- Dr. Caldera specializes in the care and treatment of patients with inflammatory bowel disease, Crohn's Disease and ulcerative colitis.
Education & Training
- University of Kentucky College of MedicineFellowship, Gastroenterology, 2008 - 2011
- University of Kentucky College of MedicineResidency, Internal Medicine, 2005 - 2008
- Des Moines University College of Osteopathic MedicineClass of 2004
Certifications & Licensure
- WI State License 2011 - 2025
- KY State License 2008 - 2012
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 8 citationsVaccination of patients with inflammatory bowel disease during the COVID-19 pandemicSheena Crosby, Michael J Schuh, Freddy Caldera, Francis A Farraye
Gastroenterology & Hepatology. 2021-01-01 - 23 citationsMethotrexate Reduces DNA Integrity in Sperm From Men With Inflammatory Bowel Disease.Dana Ley, Jeffrey P. Jones, John J. Parrish, Sana M. Salih, Freddy Caldera
Gastroenterology. 2018-06-01 - 64 citationsImmunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.Freddy Caldera, Luke Hillman, Sumona Saha, Arnold Wald, Ian Grimes
Inflammatory Bowel Diseases. 2019-08-24
Journal Articles
- Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel DiseaseMark Reichelderfer, Arnold Wald, Jeffrey Hubers, Freddy Caldera, Sumona Saha, Elizabeth Ann Misch, Mary S Hayney, Digestive Diseases and Sciences
Press Mentions
- Major Adverse Cardiovascular Events in Patients with IBD Taking Anti-TNF vs JAK Inhibitors: A Propensity Matched Cohort AnalysisOctober 30th, 2024
- Breakthrough COVID-19 Milder in Vaccinated Patients with IBDFebruary 14th, 2022
- COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: